Patil Deepa B, Lankes Heather A, Nayar Ritu, Masood Shahla, Bryk Michelle, Hou Nanjiang, Rademaker Alfred, Khan Seema A
Department of Surgery, The Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Breast Cancer Res Treat. 2008 Nov;112(2):327-33. doi: 10.1007/s10549-007-9861-8. Epub 2007 Dec 21.
Ductal lavage (DL) allows repeat sampling of breast epithelium for serial observation in a chemoprevention setting; however, the reproducibility of duct cannulation, cell yield and cytology has not been addressed.
We conducted a Phase 2 trial, wherein high risk women chose tamoxifen treatment or observation following an entry DL procedure. We present data from the non-intervention arm of our study to assess the reproducibility of cannulation, cell yield, and cytologic diagnosis from DL of the same duct at two time-points. Inter-observer variability was assessed by a blinded review of Papanicoloau-stained slides by two cytopathologists.
Sixty-five women had a successful lavage of 187 ducts at baseline and chose observation; 63/65 (97%) had a successful lavage 6 months later. Successful recannulation of the same duct was accomplished in 63 women (97%) and162 ducts (87%). Total epithelial cell yields >or=100 were obtained from 57/65 women (88%) and 129/187 ducts (69%) at baseline, and 46/63 women (73%) and 80/162 ducts (49%) at both time-points. Cytologic diagnosis was reproducible in 27/63 (43%) women and 77/162 (48%) ducts. Inter-observer variability for cytologic diagnosis between two observers showed good agreement (kappa = 0.62).
Recannulation and lavage of the same duct after a 6 month interval can be achieved with high frequency; however, reproducibility of cell yield and cytologic findings from the same duct is sub-optimal, leading to significant attrition of evaluable subjects. The utility of DL for the serial monitoring of breast epithelium is therefore limited.
导管灌洗(DL)能够重复采集乳腺上皮细胞,以便在化学预防环境中进行系列观察;然而,导管插管的可重复性、细胞产量及细胞学检查尚未得到研究。
我们开展了一项2期试验,高危女性在进行初始导管灌洗程序后选择他莫昔芬治疗或观察。我们呈现了研究中非干预组的数据,以评估在两个时间点对同一导管进行导管灌洗时插管、细胞产量及细胞学诊断的可重复性。由两名细胞病理学家对巴氏染色玻片进行盲法评估,以确定观察者间的变异性。
65名女性在基线时成功灌洗了187根导管并选择观察;6个月后,63/65(97%)的女性再次成功灌洗。63名女性(97%)和162根导管(87%)成功再次插入同一导管。基线时,57/65名女性(88%)和129/187根导管(69%)获得的上皮细胞总数≥100,两个时间点均有46/63名女性(73%)和80/162根导管(49%)达到该标准。27/63名女性(43%)和77/162根导管(48%)的细胞学诊断具有可重复性。两名观察者之间细胞学诊断的观察者间变异性显示出良好的一致性(kappa = 0.62)。
间隔6个月后对同一导管进行再次插管和灌洗的成功率较高;然而,同一导管的细胞产量及细胞学结果的可重复性欠佳,导致可评估受试者大量流失。因此,导管灌洗用于乳腺上皮细胞系列监测的效用有限。